Daniel Ranayhossaini

Role: Ocular Therapeutix, Inc.
Location: Pittsburgh, PA, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

About Daniel Ranayhossaini

Proven drug developer with 15+ years experience in discovery, research & development…

Experience

Ocular Therapeutix, Inc.
Present

Skills

Project Management
Cardiology
Histology
Advanced Microscopy
Oncology
Dna Manipulation
Pharmacology
Cell Culture
Fret
Virology
Reactive Oxygen Species
Personalized Medicine
Biologics
Drug Development
Biochemistry
Fluorescence Microscopy
Molecular Dynamics
Frap
Genomics
Drug Discovery
Toxicology
Confocal Microscopy
High Content Screening

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@ocutx.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Ocular Therapeutix, Inc.

Pharmaceutical Manufacturing · 361 employees · Founded 2006 · Bedford, Massachusetts, United States

Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience across drug development, treatment, and outcomes. AXPAXLI™ (also known as OTX-TKI), an investigational axitinib hydrogel administered by intravitreal injection, is Ocular’s leading investigational candidate for retinal disease, based on its proprietary ELUTYX™ technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD) and has potential applications across other retinal diseases such as non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME).

ocutx.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.